Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2236 AL 2250

Tackling Alzheimer's Disease with Existing Drugs: A Promising Strategy for Bypassing Obstacles

Rampa A, Gobbi S, Belluti F, Bisi A.

Curr Med Chem. 2021;28(12):2305-2327. doi: 10.2174/0929867327666200831140745.

G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer's Disease

Chakraborty S, ThimmaReddygari J, Selvaraj D.

Comb Chem High Throughput Screen. 2021;24(7):1083-1092. doi: 10.2174/1386207323666200901095003.

Sigma-2 Receptor as a Potential Drug Target

Chen AF, Ma WH, Xie XY, Huang YS.

Curr Med Chem. 2021;28(21):4172-4189. doi: 10.2174/0929867327666200902172615.

Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer's Disease and Depression

El Massry M, Alaeddine LM, Ali L, Saad C, Eid AA.

Curr Med Chem. 2021;28(12):2328-2345. doi: 10.2174/0929867327666200908114902.

From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease

Alarcón-Espósito J, Mallea M, Rodríguez-Lavado J.

Curr Neuropharmacol. 2021;19(6):832-867. doi: 10.2174/1570159X18666200914155951.

The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β

Wang K, Na L, Duan M.

Curr Top Med Chem. 2021;21(2):151-167. doi: 10.2174/1568026620666200916123000.

Diabetic Theory in Anti-Alzheimer's Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors

Jankowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2021;28(18):3535-3553. doi: 10.2174/0929867327666200917125857.

Carbon Nano Tubes: Novel Drug Delivery System in Amelioration of Alzheimer's Disease

Mishra J, Kumar B, Pandey M, Pottoo FH, Fayaz F, Khan FA, Sahoo PK.

Comb Chem High Throughput Screen. 2021;24(10):1528-1543. doi: 10.2174/1386207323999200918112538.

Phytochemicals for Drug Discovery in Alzheimer's Disease: In Silico Advances

Sharma S, Bhatia V.

Curr Pharm Des. 2021;27(25):2848-2860. doi: 10.2174/1381612826666200928161721.

Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease

Papagiouvannis G, Theodosis-Nobelos P, Kourounakis PN, Rekka EA.

Med Chem. 2021;17(10):1086-1103. doi: 10.2174/1573406416666201013161303.

Chalcones Acting as Inhibitors of Cholinesterases, β-Secretase and β- Amyloid Aggregation and other Targets for Alzheimer's Disease: A Critical Review

Antoniolli G, Almeida WP, Frias CC, de Oliveira TB.

Curr Med Chem. 2021;28(21):4259-4282. doi: 10.2174/0929867327666201020151804.

Enhancing Therapeutic Efficacy of Donepezil by Combined Therapy: A Comprehensive Review

Rong X, Jiang L, Qu M, Hassan SSU, Liu Z.

Curr Pharm Des. 2021;27(3):332-344. doi: 10.2174/1381612826666201023144836.

Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway

Ramírez-Expósito MJ, Martínez-Martos JM, Cantón-Habas V, Del Pilar Carrera-González M.

Curr Neuropharmacol. 2021;19(7):939-956. doi: 10.2174/1570159X18666201111103024.

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease

Hashioka S, Wu Z, Klegeris A.

Curr Neuropharmacol. 2021;19(7):908-924. doi: 10.2174/1570159X18666201111104509.

Naturally Inspired Pyrimidines Analogues for Alzheimer's Disease

Singh S, Dhanawat M, Gupta S, Kumar D, Kakkar S, Nair A, Verma I, Sharma P.

Curr Neuropharmacol. 2021;19(2):136-151. doi: 10.2174/1570159X18666201111110136.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias